1-(pyridazin-3-yl)ethanol
|
- $618 - $5120
- Product name: 1-(pyridazin-3-yl)ethanol
- CAS: 164738-47-0
- MF: C6H8N2O
- MW: 124.14
- EINECS:
- MDL Number:MFCD26403520
- Synonyms:1-(pyridazin-3-yl)ethanol;1-(PYRIDAZIN-3-YL)ETHAN-1-OL;3-Pyridazinemethanol, α-methyl-
5 prices
Selected condition：
Brand
- AccelPharmtech
- Chemenu
- Crysdot
Package
- 1G
- 5G
- 25G
- ManufacturerAccelPharmtech
- Product numberX0230
- Product descriptiona-methyl-3-Pyridazinemethanol 97.00%
- Packaging1G
- Price$2370
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberX0230
- Product descriptiona-methyl-3-Pyridazinemethanol 97.00%
- Packaging5G
- Price$2750
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberX0230
- Product descriptiona-methyl-3-Pyridazinemethanol 97.00%
- Packaging25G
- Price$5120
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM321727
- Product description1-(Pyridazin-3-yl)ethanol 95%
- Packaging1g
- Price$618
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11241573
- Product description1-(Pyridazin-3-yl)ethanol 95+%
- Packaging1g
- Price$654
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AccelPharmtech | X0230 | a-methyl-3-Pyridazinemethanol 97.00% | 1G | $2370 | 2021-12-16 | Buy |
| AccelPharmtech | X0230 | a-methyl-3-Pyridazinemethanol 97.00% | 5G | $2750 | 2021-12-16 | Buy |
| AccelPharmtech | X0230 | a-methyl-3-Pyridazinemethanol 97.00% | 25G | $5120 | 2021-12-16 | Buy |
| Chemenu | CM321727 | 1-(Pyridazin-3-yl)ethanol 95% | 1g | $618 | 2021-12-16 | Buy |
| Crysdot | CD11241573 | 1-(Pyridazin-3-yl)ethanol 95+% | 1g | $654 | 2021-12-16 | Buy |
Properties
Boiling point :300.7±17.0 °C(Predicted)
Density :1.160±0.06 g/cm3(Predicted)
pka :13.48±0.20(Predicted)
Density :1.160±0.06 g/cm3(Predicted)
pka :13.48±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|